Zhao C, Takita J, Tanaka Y, Setou M, Nakagawa T, Takeda S, Yang H W, Terada S, Nakata T, Takei Y, Saito M, Tsuji S, Hayashi Y, Hirokawa N
Department of Cell Biology and Anatomy, University of Tokyo, Hongo, Tokyo 113-0033, Japan.
Cell. 2001 Jun 1;105(5):587-97. doi: 10.1016/s0092-8674(01)00363-4.
The kinesin superfamily motor protein KIF1B has been shown to transport mitochondria. Here, we describe an isoform of KIF1B, KIF1Bbeta, that is distinct from KIF1B in its cargo binding domain. KIF1B knockout mice die at birth from apnea due to nervous system defects. Death of knockout neurons in culture can be rescued by expression of the beta isoform. The KIF1B heterozygotes have a defect in transporting synaptic vesicle precursors and suffer from progressive muscle weakness similar to human neuropathies. Charcot-Marie-Tooth disease type 2A was previously mapped to an interval containing KIF1B. We show that CMT2A patients contain a loss-of-function mutation in the motor domain of the KIF1B gene. This is clear indication that defects in axonal transport due to a mutated motor protein can underlie human peripheral neuropathy.
驱动蛋白超家族运动蛋白KIF1B已被证明可转运线粒体。在此,我们描述了KIF1B的一种异构体KIF1Bβ,其在货物结合结构域与KIF1B不同。KIF1B基因敲除小鼠出生时因神经系统缺陷死于呼吸暂停。培养的基因敲除神经元的死亡可通过β异构体的表达来挽救。KIF1B杂合子在转运突触小泡前体方面存在缺陷,并患有类似于人类神经病变的进行性肌肉无力。2A型夏科-马里-图斯病先前被定位到一个包含KIF1B的区间。我们发现,CMT2A患者在KIF1B基因的运动结构域存在功能丧失突变。这清楚地表明,由突变的运动蛋白导致的轴突运输缺陷可能是人类周围神经病变的基础。